Resource Centre
Discover a wealth of knowledge and insights from the experts at StarFish Medical. Our Resource Centre offers product development tips, reviews of new and cutting-edge technologies, and in-depth articles on regulatory updates and compliance in medical device development.
-
Nick and Joris break down what a DHF is, why it's required, and how it plays a vital role throughout the development lifecycle.
-
Nick and Joris explore one of the most dynamic early-phase services at StarFish Medical: the Pathfinder Program. If you're a medtech innovator with a promising concept or prototype, Pathfinder helps you identify the right path forward—before you invest millions in development.
-
Fluorescence Imaging in Medical Devices outlines medical applications and examples of devices that use fluorescence for imaging.
-
Computer Vision for Medical Devices is constantly evolving and incorporating new techniques and technologies as they emerge.
-
Being able to control the release rate of a target molecule is a valuable tool for engineering tissues and therapeutic delivery of regenerative medicine applications.
-
The human eye is an extremely delicate organ, often prone to irritation, dryness and various diseases, such as glaucoma, cataracts, keratoconus, age-related macular degeneration, and many others. These ocular clinical conditions also affect patients’ quality of life.
-
Exploration of drug-device combination therapies that are transforming the treatment of Parkinson’s, epilepsy, depression, and brain cancer.
-
What are the real costs of developing a medical device? In this episode of Bio Break, Nick and Joris dive into one of the most frequently asked questions they hear from clients: How much does it cost to develop a medical device?
-
We all know medical devices have labels, but how often do we consider their purpose and the effort required to ensure they provide the right information? Device labelling serves as the interface between the manufacturer, the user, and regulatory bodies. (Note that being from Canada, we spell labelling with two Ls.)
